Sector ratings IXICO plc

Equities

Delayed London S.E. Other stock markets 03:42:04 2025-12-08 EST			5-day change	1st Jan Change
10.04 ^GBX	-6.63%		-8.75%	-14.57%

12-01	IXICO plc Announces Scientific Advisory Board Appointments, Effective December 1, 2025	CI
11-17	Ixico wins GBP3.7 million deal to support Huntington's Disease trial	AN

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
IXICO PLC	13.27M	-	-	-		-	-	-
LONZA GROUP AG	47.37B		AAA
IQVIA HOLDINGS INC.	38.46B		AAA
BEONE MEDICINES AG	35.73B		-
CELLTRION, INC.	27.23B		A
MEDPACE HOLDINGS, INC.	15.44B		BBB
REVOLUTION MEDICINES, INC.	15.4B	-	B	-		-
ICON PUBLIC LIMITED COMPANY	14.19B		AA
TEMPUS AI, INC.	13.64B	-	A	-		-
IONIS PHARMACEUTICALS, INC.	13.23B	-	A	-		-
ASCENDIS PHARMA A/S	12.55B	-	-	-		-
EUROFINS SCIENTIFIC SE	12.12B		AA
QIAGEN N.V.	10.19B		AAA
BIO-TECHNE CORPORATION	9.61B		A
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	9.07B		A
BLUEPRINT MEDICINES CORPORATION	8.38B	-	BB	-		-	-	-
ABIVAX	8.29B	-	BBB	-		-
REGENCELL BIOSCIENCE HOLDINGS LIMITED	8.03B	-	-	-	-	-	-	-
PHARMARON BEIJING CO., LTD.	6.92B		AA
PRAXIS PRECISION MEDICINES, INC.	6.2B	-	B	-		-
Average	15.6B		A
Weighted average by Cap.			A